Navigation Links
Trius Reports New Findings on Mechanisms of Antibiotic Resistance in MRSA
Date:9/13/2010

SAN DIEGO, Sept. 13 /PRNewswire-FirstCall/ -- Trius Therapeutics, Inc. (Nasdaq: TSRX) today reported  new findings on torezolid phosphate (TR-701), a second generation oxazolidinone antibiotic now in Phase 3 clinical development. The data elucidate the mechanism by which torezolid retains full activity against clinical isolates of Staphylococcus aureus (S. aureus) carrying the cfr gene which confers resistance to first generation oxazolidinones such as linezolid, marketed by Pfizer as Zyvox®.  Hospital outbreaks of linezolid resistant cfr strains of methicillin resistant Staphylococcus aureus (MRSA) have been reported worldwide and increasing use of linezolid may promote further dissemination of this plasmid borne resistance gene. Two separate articles featuring discussion of these data have been published online ahead of print on September 13 in Antimicrobial Agents and Chemotherapy (AAC), a peer-reviewed journal of the American Society for Microbiology.

S. aureus that express the cfr gene possess ribosomes that are structurally altered in a way that inhibits the binding of first generation oxazolidinone antibiotics such as linezolid, as well as the binding of antibiotics of other classes, such as the pleuromutilins, phenicols, lincosamides, and streptogramins. Torezolid's potent activity is preserved against cfr strains of S. aureus due to its unique structural features.

"Recent outbreaks of cfr strains of MRSA have fueled concerns that this pathogen will inevitably proliferate given the broad usage of linezolid and generic antibiotics that select for the plasmid borne cfr resistance gene," said Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius and corresponding author on the papers.  "The potent activity of torezolid against cfr-positive bacteria diff
'/>"/>

SOURCE Trius Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trius to Present at the Stifel Nicolaus Healthcare Conference
2. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
3. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
4. Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
5. Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
6. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
7. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
8. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
9. Trius Doses First Patient in Antibacterial Phase 2 Trial
10. PacificGMP Completes GMP Product Fill for Trius Therapeutics
11. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the ... China, today announced its unaudited financial results for the ... 2015 Financial Highlights , Total sales in ... $70.4 million from $56.3 million in the same quarter ... to $45.9 million from $38.6 million in the same ...
(Date:5/6/2015)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... first quarter ended March 31, 2015. "The ... product sales driven by HETLIOZ and Fanapt.  As we ... Non-24 patients in the U.S., the growth potential for ... Fanapt underscores the growth potential of this product through ...
(Date:5/6/2015)... -- Lannett Company, Inc. (NYSE: LCI ) today ... ended March 31, 2015.  For the ... $99.4 million from $80.0 million in last year,s third ... 76% of net sales, from $56.1 million, or 70% ... to $9.2 million from $10.6 million for the fiscal ...
Breaking Medicine Technology:China Biologic Reports Financial Results for the First Quarter of 2015 2China Biologic Reports Financial Results for the First Quarter of 2015 3China Biologic Reports Financial Results for the First Quarter of 2015 4China Biologic Reports Financial Results for the First Quarter of 2015 5China Biologic Reports Financial Results for the First Quarter of 2015 6China Biologic Reports Financial Results for the First Quarter of 2015 7China Biologic Reports Financial Results for the First Quarter of 2015 8China Biologic Reports Financial Results for the First Quarter of 2015 9China Biologic Reports Financial Results for the First Quarter of 2015 10China Biologic Reports Financial Results for the First Quarter of 2015 11China Biologic Reports Financial Results for the First Quarter of 2015 12China Biologic Reports Financial Results for the First Quarter of 2015 13China Biologic Reports Financial Results for the First Quarter of 2015 14China Biologic Reports Financial Results for the First Quarter of 2015 15China Biologic Reports Financial Results for the First Quarter of 2015 16China Biologic Reports Financial Results for the First Quarter of 2015 17China Biologic Reports Financial Results for the First Quarter of 2015 18Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 10Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 11Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 12Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8
... & White Healthcare has acquired approximately 98 acres of ... new 143-bed acute care hospital project. The property was ... The five-story, 320,000-square-foot Scott & White ... Texas Hwy 6 and Rock Prairie Road. Construction is ...
... Delcath Systems, Inc. (Nasdaq: DCTH ) today ... of its 505(b)(2) New Drug Application (NDA) for its ... Administration (FDA). The Company had previously submitted Module 4, ... in late April 2010. The Company is seeking an ...
Cached Medicine Technology:Scott & White Finalizes College Station Land Deal 2Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System 2Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System 3
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... Ace Care, has recently announced that they will now ... replacement, for strata complexes in addition to commercial and ... large scale and require a lot of technical knowledge ... “When we do an installation we will take away ...
(Date:5/6/2015)... Chesapeake Regional Medical Center is ... to acquire Intuitive Surgical, Inc.’s latest model of ... includes enhanced surgical technique capabilities, which can be ... wide spectrum of specialties. Its advancements allow patients ... recovery times. , “As the only independent, community-based ...
(Date:5/6/2015)... 2015 Prime Pacific Health Innovations, ... to announce a new series of universal, one-time-use ... carbon footprint while improving treatment efficacy and saving ... the world’s first waste hose designed specifically ... hydrotherapists,” claims the company’s president, Mr. Delmar Vogel. ...
(Date:5/6/2015)... 06, 2015 The Beryl Institute announces ... of Patient Experience Journal (PXJ), an international, open access, ... understanding and improving patient experience. The second volume of ... conversation globally, helps align the voices engaged and provides ... Published in association with The Beryl Institute, Volume 2, ...
(Date:5/6/2015)... 2015 Animals make just as good friends ... good for your health. An Ohio veterinarian has ... he's seeing with health advantages of owning a pet. , ... comes to pet ownership, there are proven health benefits for ... Leffler of the Animal Medical Center of Streetsboro ...
Breaking Medicine News(10 mins):Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3
... nursing,leader Sally Watkins, PhD(c), MS, RN, has been ... by the Washington State Nurses,Association (WSNA), the State,s ... "We are very fortunate to have in Sally ... patient and nurse advocate," said WSNA Executive,Director Judy ...
... in a mid-August edition of Circulation: Journal of the America ... healthy eating habits, it can strongly influence their heart disease ... Turku Coronary Risk Factor Intervention Project have landmark implications on ... study, a childs fat intake, primarily reduction in intake of ...
... industry is riding the green wave back into public ... our growing energy needs. But even as the industry ... it is bound by a global energy landscapefrom solar ... marketplace. , Veteran New York Times energy reporter ...
... Sept. 11 (HealthDay News) -- Carvedilol, a newer member of the ... heart failure, did not help children with the condition, a new ... of it -- was almost exactly the same for 103 young ... who got a placebo. , "Heart failure in children is both ...
... resulted in a cancer diagnosis among a population of ... not find cancer often had multiple biopsies in the ... , While PSA (prostate-specific antigen) tests have become ... what actually determines the presence of prostate cancer. Nonetheless, ...
... A new American Cancer Society study finds having at least ... risk of cancer death. The study finds higher education levels ... white men, and white women. The difference in mortality for ... years of education and those with more than 12 years. ...
Cached Medicine News:Health News:New Director of Nursing Practice Named for Nurses Association 2Health News:Children who learn heart healthy eating habits lower heart disease risk 2Health News:Children who learn heart healthy eating habits lower heart disease risk 3Health News:Trade-offs reveal no clear favorites in alternative energy market 2Health News:Beta Blocker Doesn't Help Children With Heart Failure 2Health News:Other highlights in the September 11 JNCI 2Health News:Other highlights in the September 11 JNCI 3Health News:Study links education to risk of cancer death 2Health News:Study links education to risk of cancer death 3
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
... optimize the accuracy and precision of Finnpipettes. ... widely recognized by customers throughout the world. ... the years and now covers a full ... filter tips, certified pure tips, stepper tips ...
MBP's 200 L large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
Medicine Products: